comprehensive -WSS

comprehensive

author：knowledge 2025-08-11 08:00:28 - browse：33

Portrait of Robert Langer. -- biotech coverage from STAT. — Serial biotech entrepreneur Bob Langer will serve as an adviser to T.rx Capital. Pat Greenhouse/Globe Staff

Executives from the shuttered digital health company Pear Therapeutics are launching a new VC firm, offering early access to new startups formed by serial biotech entrepreneur Bob Langer.

Former Pear CEO Corey McCann and former licensing head Michael Langer formed the new firm, T.rx Capital, earlier this year, according to three people with knowledge of the firm and documents reviewed by STAT. Michael Langer, the son of Bob Langer, confirmed the news and that they had set a $175 million cap for its first fund.

The firm will invest in therapeutics and digital health products by both forming new companies and taking pitches from early-stage startups. T.rx has brought in Everly Health executive Liz Kwo and Caris Life Sciences vice president Debbie Lin as venture partners, while current Eli Lilly business development team member Kwesi Frimpong-Boateng will be joining T.rx’s founding team. Bob Langer is a scientific adviser.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Telehealth startups are trying to fill the menopause care vacuum

WSS

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

Delta passengers in Vegas fall sick while waiting on flight in triple

SEC charges former device maker CEO with $41 million fraud

Hormonal contraceptives don’t actually treat endometriosis

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

What STAT readers think about the FDA and patient advocacy

focus

comprehensive

focus

What does generative AI mean for health care? We asked experts

Prime Medicine, Myeloid Therapeutics clash over genome

Sports medicine is finally prioritizing gender equality

Sanders wants to replace patents with prizes for drug inventions

Continuity nursing helped my family in our darkest PICU moments

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Hepatitis C has a cure — but many Americans still lack access to it

Three trends to watch in biotech in 2024

How to save PrEP access — and even expand it

Dementia risk linked to living in disadvantaged areas: Study

entertainment

Are infertility treatments 'essential' during the Covid

Can sheer will power keep patients alive in their dying hours?

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

What STAT readers think about the FDA and patient advocacy

'CMA Fest' 2023: How to watch, who is performing and more

A new ‘biological computer' targets cancer while sparing healthy cells

explore

leisure time

hotspot

focus